EP1373348A1 - Eponges cosmetiques - Google Patents

Eponges cosmetiques

Info

Publication number
EP1373348A1
EP1373348A1 EP02737875A EP02737875A EP1373348A1 EP 1373348 A1 EP1373348 A1 EP 1373348A1 EP 02737875 A EP02737875 A EP 02737875A EP 02737875 A EP02737875 A EP 02737875A EP 1373348 A1 EP1373348 A1 EP 1373348A1
Authority
EP
European Patent Office
Prior art keywords
acid
sponge
derivatives
carrier according
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02737875A
Other languages
German (de)
English (en)
Inventor
James Allan Smith
Wolfhard Scholz
Heike Schelges
Armin Wadle
Bernhard Banowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Regenesis LLC
Original Assignee
Regenesis LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10208678A external-priority patent/DE10208678A1/de
Application filed by Regenesis LLC filed Critical Regenesis LLC
Publication of EP1373348A1 publication Critical patent/EP1373348A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
    • A47K—SANITARY EQUIPMENT NOT OTHERWISE PROVIDED FOR; TOILET ACCESSORIES
    • A47K7/00—Body washing or cleaning implements
    • A47K7/02—Bathing sponges, brushes, gloves, or similar cleaning or rubbing implements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/87—Polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08—Processes
    • C08G18/10—Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/002—Aftershave preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/04—Preparations for permanent waving or straightening the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A61Q5/065—Preparations for temporary colouring the hair, e.g. direct dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2101/00—Manufacture of cellular products

Definitions

  • the present invention relates to flexible, fine-pored, liquid-treated sponges based on a polyurethane foam, which as an in-situ reaction product of a urethane prepolymer with free isocyanate groups and an aqueous phase, the at least one surface-active substance and cosmetic or dermatological effect - or contains care substances.
  • the sponges are used for cosmetic or dermatological treatment of the skin, hair, mucous membrane and the appendages of the skin.
  • Flexible carriers e.g. B. wipes and pads that are impregnated or impregnated with liquid cosmetic compositions are very popular with consumers. They are time-saving, clean and hygienic to use.
  • the straps often consist of non-woven fleece, cotton or microfibers.
  • Cosmetic sponges based on in-situ reaction products made of a urethane prepolymer with free isocyanate groups and an aqueous phase are known in the art.
  • the US Pat. No. 4,806,572 describes pads which are formed in situ from a urethane prepolymer with free isocyanate groups and an oil-in-water emulsion and are used for removing makeup.
  • the emulsion contains anionic and nonionic surfactants as well as liquid oil components and is free from natural or synthetic waxes.
  • US Pat. No. 4,548,954 describes an oil-absorbent floor cleaning agent which is formed in situ from a urethane prepolymer with free isocyanate groups and an aqueous silicone oil emulsion which contains abrasive particles.
  • US Pat. No. 4,127,515 describes a floor waxing and polishing agent which is formed in situ from a urethane prepolymer with free isocyanate groups and an aqueous wax-containing silicone oil emulsion which contains a polyacrylate.
  • the foaming process and the quality of the end product depend to a large extent on the composition of the liquid used. It was therefore new and surprising for the person skilled in the art that the in-situ reaction product of a urethane prepolymer with free isocyanate groups and a surfactant- or emulsifier-containing liquid water-containing phase, which contains further cosmetic or dermatological active ingredients and care substances, is flexible , fine-pored sponges are obtained, which are pleasantly slippery on the skin and hair surfaces to be treated and allow a controlled, drip-free release of the liquid bound in the pores.
  • the foams according to the invention can be cured, cut or punched in any shape that is optimally adapted to the respective area of application.
  • the invention relates to a flexible, equipped carrier based on a polyurethane foam for cosmetic or dermatological treatment of the skin, hair, mucous membrane and appendages, containing the in-situ reaction product of a urethane prepolymer with free isocyanate groups with a liquid water-containing phase, which contains at least one surface-active substance and at least one dispersed fatty substance and is characterized in that the liquid phase further contains at least one cosmetic or dermatological active substance or care substance, which is selected from natural, optionally chemically modified polymers, which in turn are selected from cellulose ethers, quaternized cellulose derivatives, polyquaternium-24, guar gum, cationic guar derivatives, alginates, xanthan gum, gum arabic, karaya gum, locust bean gum, linseed gums, dextrans, shellac, amylose, amylopectin, dextrins Hemically and / or thermally modified starches as well as chitos
  • Urethane prepolymer compositions suitable for producing the sponges according to the invention are described, for example, in US Pat. Nos. 3,903,232 and 4,137,200.
  • Corresponding commercial products come from the Hypol ® product range from WR Grace & Co, Lexington, MA, Hypol ® FHP 5000, Hypol ® FHP 4000, Hypol ® FHP 3000, Hypol ® FHP 2000, Hypol ® FHP 2000 HD, Hypol ® FHP 2002, Hypol ® 2000, Hypol ® 2002, Hypol ® 3000, Hypol ® X6100 and Hypol ® Hydrogel.
  • the liquid resins are made by reacting low molecular weight polyols with 3 to 8 hydroxyl groups with aromatic or aliphatic diisocyanates. After the reaction, the resins have at least two free isocyanate groups per molecule of alcohol used.
  • Suitable diisocyanates are e.g. B. toluene diisocyanate, methylene diphenyl isocyanate and isophorone diisocyanate. More suitable Commercial products come from the Aquapol ® product range from Freeman Chemical Corporation and from the Trepol ® product range from Twin Rivers Engineering.
  • the free isocyanate groups of the urethane prepolymer hydrolyze with the release of carbon dioxide. This forms fine-pored sponges that are equipped with the active ingredient-containing aqueous phase.
  • the foam composition can then be brought into various shapes adapted to the respective application area using suitable processes known to the person skilled in the art.
  • surfactants or emulsifiers are selected from anionic, cationic, zwitterionic, ampholytic and nonionic surfactants and emulsifiers.
  • Suitable anionic surfactants and emulsifiers in preparations according to the invention are all anionic surface-active substances suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. B. a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group with about 8 to 30 carbon atoms.
  • anionic group such as. B. a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group with about 8 to 30 carbon atoms.
  • the molecule can contain glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups.
  • R 1 CO represents a linear or branched acyl radical having 6 to 22 carbon atoms and 0, 1, 2 or 3 double bonds and X represents hydrogen, an alkali metal and / or alkaline earth metal, ammonium, alkylammonium, alkanolammonium or glucammonium, for example acylglutamates, which are derived from fatty acids having 6 to 22, preferably 12 to 18 carbon atoms, such as C 12/14 or C 12/18 coconut fatty acid, lauric acid, myristic acid, palmitic acid and / or stearic acid, in particular sodium N-cocoyl and Sodium N-stearoyl-L-glutamate, ester of a hydroxy-substituted di- or tricarboxylic acid of the general formula (II),
  • X H or a -CH 2 COOR group
  • R, R 1 and R 2 are independent of each other is a hydrogen atom, an alkali metal or alkaline earth metal cation, an ammonium group, the cation of an ammonium organic base or a radical Z which derives from a polyhydroxylated organic compound which is selected from the group of etherified (C 6 -C 18 ) -alkylpolysaccharides with 1 to 6 monomeric saccharide units and / or the etherified aliphatic (C 6 -C 16 ) hydroxyalkyl polyols having 2 to 16 hydroxyl radicals are selected, provided that at least one of the groups R, R 1 or R 2 is a Z radical, an ester of Sulfosuccinic acid or the sulfosuccinates of the general formula (III),
  • Alkyl sulfates and alkyl polyglycol ether sulfates of the formula R- (O-CH 2 -CH 2 ) x -OSO 3 H, in which R is a preferably linear alkyl group with 8 to 30 C atoms and x 0 or 1-12,
  • Esters of tartaric acid and citric acid with alcohols which are adducts of about 2-15 molecules of ethylene oxide and / or propylene oxide with C 8-22 fatty alcohols,
  • Preferred anionic surfactants and emulsifiers are acyl glutamates, acyl isethionates, acyl sarcosinates and acyl taurates, each with a linear or branched acyl radical having 6 to 22 carbon atoms and 0, 1, 2 or 3 double bonds, which in particularly preferred embodiments consist of an octanoyl, decanoyl or lauroyl -, myristoyl, palmitoyl and stearoyl radical is selected, esters of tartaric acid, citric acid or succinic acid or the salts of these acids with alkylated glucose, in particular the products with the INCI name Disodium Coco-Glucoside Citrate, Sodium Coco Glucoside tartrates and disodium coco-glucoside sulfosuccinates, alkyl polyglycol ether sulfates and ether carboxylic acids with 8 to 18 C atoms in the alkyl group and up to 12 ethoxy groups
  • Zwitterionic surfactants and emulsifiers are those surface-active compounds which carry at least one quaternary ammonium group and at least one -COO ⁇ - or -SOa ⁇ group in the molecule.
  • Particularly suitable zwitterionic surfactants and emulsifiers are the so-called betaines such as the N-alkyl-N, N-dimethylammonium glycinate, for example the cocoalkyldimethylammonium glycinate, N-acyl-aminopropyl-N, N-dimethylammonium glycinate, for example the cocoacylaminopropyldimethylammonium glycinate 3, and 2 -carboxymethyl-3-hydroxyethylimidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and the cocoacylaminoethylhydroxyethylcarboxymethylglycinate.
  • Ampholytic surfactants and emulsifiers are understood to mean those surface-active compounds which, in addition to a C 8 -C 24 alkyl or acyl group, contain at least one free amino group and at least one -COOH or -SO 3 H group and are capable of forming internal salts
  • suitable ampholytic surfactants are N-alkylglycine, N-alkylaminopropionic acid, N-alkylaminobutyric acid, N-alkyliminodipropionic acid, N-hydroxyethyl-N-alkylamidopropylglycine, N-alkyltaurine, N-alkyl sarcosine, 2-alkylaminopropionic acid and alkylaminoacetic acid each with about 8 to 24 C. Atoms in the alkyl group.
  • Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C 12
  • Nonionic surfactants and emulsifiers contain z as hydrophilic group. Legs
  • Polyol group a polyalkylene glycol ether group or a combination of polyol and
  • Adducts of 5 to 60 moles of ethylene oxide with castor oil and hardened castor oil Adducts of 5 to 60 moles of ethylene oxide with castor oil and hardened castor oil
  • Polyol fatty acid (partial) esters such as Hydagen ® HSP (Cognis) or Sovermol ® types (Cognis), in particular saturated C 8-30 fatty acids,
  • Sorbitan fatty acid esters and addition products of ethylene oxide onto sorbitan fatty acid esters such as, for example, the polysorbates
  • Any mono- or oligosaccharides can be used as sugar building block Z.
  • Sugar with 5 or 6 carbon atoms and the corresponding oligosaccharides are usually used.
  • sugars are glucose, fructose, galactose, arabinose, ribose, xylose, lyxose, allose, old rose, mannose, gulose, idose, talose and sucrose.
  • Preferred sugar units are glucose, fructose, galactose, arabinose and sucrose; Glucose is particularly preferred.
  • alkyl polyglycosides which can be used according to the invention contain on average 1.1 to 5 sugar units. Alkyl polyglycosides with x values from 1.1 to 2.0 are preferred. Alkyl glycosides in which x is 1.1 to 1.8 are very particularly preferred.
  • alkyl (oligo) glucosides and fatty alcohols e.g. B. Montanov ® 68
  • - sterols e.g. B. ergosterol
  • stigmasterol sitosterol and mycosterols
  • phospholipids e.g. B. lecithins or phosphatidyl choiins
  • Polyglycerols and polyglycerol derivatives such as, for example, polyglycerol poly-12-hydroxystearate (Dehymuls ® PGPH) or triglycerol diisostearate (Lameform ® TGI),
  • alkyl polyglycosides optionally in a mixture with fatty alcohols, alkoxylated polydialkylsiloxanes, alkylene oxide adducts with saturated linear fatty alcohols and fatty acids, each with 2 to 30 moles of ethylene oxide per mole of fatty alcohol or fatty acid, have proven to be preferred nonionic surface-active substances.
  • Cationic surfactants of the type of the quaternary ammonium compounds, the esterquats and the amidoamines can also be used according to the invention.
  • Preferred quaternary ammonium compounds are ammonium haiogenides, in particular chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides.
  • the long alkyl chains of these surfactants preferably have 10 to 18 carbon atoms, such as. B.
  • cetyltrimethylammonium chloride cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride.
  • Further preferred cationic surfactants are the imidazolium compounds known under the INCI names Quatemium-27 and Quaternium-83.
  • Ester quats are surface-active substances which contain both at least one ester function and at least one quaternary ammonium group as a structural element.
  • Preferred ester quats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines.
  • the alkylamidoamines are usually produced by amidation of natural or synthetic fatty acids and fatty acid cuts with dialkylaminoamines.
  • An invented According to the invention a particularly suitable compound from this group of substances is stearamidopropyldimethylamine, for example the commercial product Tegoamid ® S 18.
  • the total surface-active substances are used in amounts of 0.1-45% by weight, preferably 0.1-30% by weight. % and very particularly preferably from 0.5 to 15% by weight, based on the composition used to foam the sponges according to the invention.
  • the anionic surfactants and emulsifiers are contained in the agents according to the invention preferably in amounts of 0.1 to 30% by weight, particularly preferably 1 to 15% by weight, based on the composition used to foam the sponges according to the invention.
  • the zwitterionic surfactants and emulsifiers are present in the agents according to the invention preferably in amounts of 0.1 to 30% by weight, particularly preferably 1 to 15% by weight, based on the composition used to foam the sponges according to the invention.
  • ampholytic surfactants and emulsifiers are contained in the agents according to the invention preferably in amounts of 0.1 to 15% by weight, particularly preferably 1 to 10% by weight, based on the composition used to foam the sponges according to the invention.
  • the nonionic surfactants and emulsifiers are present in the agents according to the invention preferably in amounts of 0.1 to 30% by weight, particularly preferably 1 to 15% by weight, based on the composition used to foam the sponges according to the invention.
  • the cationic surfactants are present in the agents according to the invention preferably in amounts of 0.1 to 10% by weight, particularly preferably 0.5 to 5% by weight, based on the composition used to foam the sponges according to the invention.
  • the liquid, water-containing phases with which the carriers according to the invention are prepared can preferably be at least one nonionic emulsifier with an HLB value of 3 to 18, according to the method described in the Römpp Lexicon Chemie (Hrg. J. Falbe, M. Regitz), 10 Edition, Georg Thieme Verlag Stuttgart, New York, (1997), page 1764.
  • Nonionic O ⁇ / V emulsifiers with an HLB value of 10-15 and nonionic W / O emulsifiers with an HLB value of 3-6 can be particularly preferred according to the invention.
  • the fatty substances used according to the invention are understood to mean fatty acids, fatty alcohols and natural and synthetic waxes, which can be present both in solid and liquid form in aqueous dispersion, and natural and synthetic cosmetic oil components.
  • Perfume oils and essential oils are also included in the fatty substances according to the invention.
  • Linear and / or branched, saturated and / or unsaturated C 8 can be used as fatty acids. 30 fatty acids. C 10 are preferred. 22 fatty acids. Examples are isostearic acids and isopaimitic acids. Other suitable examples are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, araachidonic acid, elaeaididearic acid, Behenic acid and erucic acid and their technical mixtures.
  • the fatty acid cuts which are obtainable from coconut oil or palm oil are usually particularly preferred; the use of stearic acid is particularly preferred.
  • the amount used is 0.1-15% by weight, preferably 0.5-10% by weight and particularly preferably 1-5% by weight, in each case based on the composition used to foam the sponges according to the invention.
  • Saturated, mono- or polyunsaturated, branched or unbranched fatty alcohols having 6 to 30, preferably 10 to 22 and very particularly preferably 12 to 22 carbon atoms can be used as fatty alcohols.
  • octenol dodecenol, decenol, octadienol, dodecadienol, decadienol, oleyl alcohol, eruca alcohol, ricinol alcohol, stearyl alcohol, isostearyl alcohol, cetyl alcohol, lauryl alcohol, myristyl alcohol, arachidyl alcohol, capoleyl alcohol, capole alcohol, capole alcohol, capole alcohol their Guerbet alcohols.
  • Solid paraffins or isoparaffins plant waxes such as candelilla wax, carnauba wax, esparto grass wax, fruit waxes and sunflower wax, beeswaxes and other insect waxes, ozokerites, ceresine, walnut and microwaxes made of polyethylene or polypropylene can be used according to the invention as natural or synthetic waxes.
  • plant waxes such as candelilla wax, carnauba wax, esparto grass wax, fruit waxes and sunflower wax
  • beeswaxes and other insect waxes ozokerites
  • ceresine walnut and microwaxes made of polyethylene or polypropylene
  • triglycerides of saturated and optionally hydroxylated C 16-30 fatty acids such as. B.
  • hardened triglyceride fats hydrogenated palm oil, hydrogenated coconut oil, hydrogenated castor oil
  • glyceryl tribehenate or glyceryl tri-12-hydroxy stearate further synthetic full esters of fatty acids and glycols (e.g. Syncro- wax ®) or polyols having 2 - 6 carbon atoms, fatty acid monoalkanolamides with a C 12- 22 acyl group and a C 2-4 alkanol, synthetic fatty acid Fettalkoholester, z. B.
  • ester waxes from natural fatty acids and synthetic C 20-40 fatty alcohols ICI name C20-40 alkyl stearates
  • full esters from fatty alcohols and di- and tricarboxylic acids eg. B. dicetyl succinate or dicetyl / stearyl adipate, and mixtures of these substances.
  • the natural and synthetic cosmetic oil bodies which can advantageously be used according to the invention include, for example:
  • oils examples include sunflower oil, olive oil, soybean oil, rapeseed oil, almond oil, jojoba oil, orange oil, wheat germ oil, peach seed oil and the liquid components of coconut oil.
  • triglyceride oils such as the liquid portions of beef tallow and synthetic triglyceride oils are also suitable.
  • B. 1, 3-di- (2-ethyl-hexyl) cyclohexane (Cetiol ® S) and di-n-alkyl ether with a total of 12 to 36, in particular 12 to 24 carbon atoms, such as.
  • 1,3-Di- (2-ethylhexyl) cyclohexane (Cetiol ® S) and di-n-octyl ether (Cetiol ® OE) may be preferred.
  • esters of C 6-30 fatty acids with C 2-30 - fatty alcohols are preferred.
  • the monoesters of fatty acids with alcohols having 2 to 24 carbon atoms are preferred.
  • Dicarboxylic acid esters such as di-n-butyl adipate, di- (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecylacelate as well as diol esters such as ethylene glycol dioleate, ethylene glycol di-isotridecanoate, propylene glycol di (2-ethylhexanoate ), Propylene glycol di-isostearate, propylene glycol di-pelargonate, butanediol di-isostearate, neopentyl glycol di-caprylate,
  • hydroxycarboxylic acid esters are full esters of glycolic acid, lactic acid, malic acid, tartaric acid or citric acid.
  • Other basically suitable hydroxycarboxylic acid esters are esters of ⁇ -hydroxypropionic acid, tartronic acid, D-gluconic acid, sugar acid, mucic acid or glucuronic acid.
  • Primary linear or branched aliphatic alcohols with 8-22 C atoms are suitable as the alcohol component of these esters.
  • the esters of C 12 -C 15 fatty alcohols are particularly preferred. Esters of this type are available under the trademark Cosmacol ® (Eni Chem. Augusta Industriale), for example.
  • esters of the 2-position branched C 12-13 alkanols with 2-ethylhexanoic acid for example the commercial product Cosmacol ® EOI.
  • the amount of the hydroxycarboxylic acid esters used is 0.1-15% by weight, preferably 0.1-10% by weight and particularly preferably 0.1-5% by weight, in each case based on the weight of the sponges according to the invention for foaming used composition.
  • siloxanes can be in the form of oils, resins, elastomers or gums.
  • Preferred siloxanes are polydialkylsiloxanes, such as. B. polydimethylsiloxane, polyalkylarylsiloxanes, such as. B. polyphenylmethylsiloxane, polydialkylsiloxanes containing amine and / or hydroxyl groups and cyclic silicones (INCI name: Cyclomethicone), preferably decamethylcyclopentasiloxane and dodecamethylcyclohexasiloxane.
  • Suitable perfume oils are, for example, mixtures of natural and synthetic fragrances.
  • Natural fragrances are extracts of flowers (lily, lavender, roses, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (anise, coriander, caraway, juniper), fruit peel (bergamot, lemon, Oranges), roots (mace, angelica, celery, cardamom, costus, iris, calmus), wood (pine, sandal, guaiac, cedar, rosewood), herbs and grasses (tarragon, lemongrass, sage, thyme), Needles and twigs (spruce, fir, pine, mountain pine), resins and balms (galbanum, elemi, benzoin, myrrh, olibanum, opoponax).
  • Typical synthetic fragrance compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type. Fragrance compounds of the ester type are, for example, benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinylacetate, phenylethyl acetate, linalyl benzoate, benzyl formate, ethyl methylphenyl glycinate, allyl cyclohexyl benzylatepylpropionate, stally.
  • the ethers include, for example, benzyl ethyl ether, the aldehydes, for example, the linear alkanals with 8-18 C atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamenaldehyde, hydroxycitronellal, lilial and bourgeonal, the ketones, for example, the ionones, ⁇ -isomethylionone and methylcedryl ketone the alcohols anethole, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpineol.
  • the hydrocarbons mainly include the terpenes and balms. However, preference is given to using mixtures of different fragrances which together produce an appealing fragrance.
  • Essential oils of lower volatility which are mostly used as aroma components, are also suitable as perfume oils, e.g. Sage oil, family oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labolanum oil and lavandin oil.
  • the perfume oil and / or essential oil is contained in amounts of 0.01-2% by weight, preferably 0.1-1% by weight, based in each case on the weight of the composition used to foam the sponges according to the invention.
  • the total amount of oil and fat components in the agents according to the invention is usually 0.01-60% by weight, preferably 0.1-35% by weight and particularly preferably 1-20% by weight, in each case based on the weight of the composition used to foam the sponges according to the invention.
  • the natural, if desired chemically modified, polymers preferably used according to the invention include cellulose ethers, e.g. B. hydroxypropyl cellulose, carboxymethyl cellulose, hydroxyethyl cellulose and methyl hydroxypropyl cellulose, quaternized cellulose derivatives, such as. B.
  • Celquat ® and Polymer JR ® and particularly preferably Celquat ® H 100, Celquat ® L 200 and Polymer JR ® 400, the known under the names Polyquaternium-24 polymers, guar gum, cationic guar derivatives, especially the Products Cosmedia ® Guar and Jaguar ® , alginates, xanthan gum, gum arabic, karaya gum, locust bean gum, linseed gums, dextrans, shellac, starch fractions such as amylose, amylopectin and dextrins, chemically and / or thermally modified starches such as B.
  • Polyquaternium-24 polymers guar gum, cationic guar derivatives, especially the Products Cosmedia ® Guar and Jaguar ® , alginates, xanthan gum, gum arabic, karaya gum, locust bean gum, linseed gums, dextrans, shellac, starch fractions such as amylose,
  • chitosan aluminum starch octenyl succinate (Dry Flo ® Plus) or hydroxypropyl starch phosphate, chitosan and its derivatives, such as. B. the products Hydagen ® CMF, Hydagen ® HCMF, Kytamer ® PC and Chitolam ® NB / 101. Chitosans which are particularly suitable have a degree of deacetylation of at least 80% and a molecular weight of 5 ⁇ 10 5 to 5 ⁇ 10 6 g / mol. For the use according to the invention, the chitosan must be converted into the salt form. Suitable acids are z. B. acetic acid, glycolic acid, tartaric acid, malic acid, citric acid, lactic acid, 2-pyrrolidone-5-carboxylic acid, benzoic acid or salicylic acid.
  • the synthetic polymers preferably used according to the invention which do not act as superabsorbents, but swell with water and thereby pass into a gel-like real or colloidal solution, can be anionic, cationic, amphoteric or non-ionic.
  • Suitable anionic synthetic polymers contain carboxylate and / or sulfonate groups and as monomers, for example acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid.
  • the acidic groups can be present in whole or in part as sodium, potassium, ammonium, mono- or triethanolammonium salt.
  • Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid.
  • Very particularly preferred anionic polymers contain 2-acrylamido-2-methylpropanesulfonic acid as the sole monomer or as comonomer, the sulfonic acid group being entirely or can be partially in salt form.
  • the homopolymer of 2-acrylamido-2-methylpropanesulfonic acid e.g. B. the product Rheothik ® 11-80.
  • copolymers of at least one anionic monomer and at least one nonionic monomer are acrylamide, methacrylamide, acrylic acid esters, methacrylic acid esters, vinyl pyrrolidone, vinyl ethers and vinyl esters.
  • Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with monomers containing sulfonic acid groups.
  • a particularly preferred anionic copolymer consists of 70-55 mol% of acrylamide and 30-45 mol% of 2-acrylamido-2-methylpropanesulfonic acid, the sulfonic acid groups in whole or in part as sodium, potassium, ammonium, mono- or ethanol-ammonium Salt.
  • This copolymer can also be crosslinked, with polyolefinically unsaturated compounds such as tetraallyloxyethane, allyl sucrose, allylpentaerythritol and methylene bisacrylamide preferably being used as crosslinking agents.
  • polyolefinically unsaturated compounds such as tetraallyloxyethane, allyl sucrose, allylpentaerythritol and methylene bisacrylamide preferably being used as crosslinking agents.
  • Such a polymer is contained in the commercial product Sepigel ® 305 from SEPPIC.
  • anionic homopolymers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene can be preferred crosslinking agents. Such compounds are, for example, the commercial products Carbopol ® . Further particularly preferred anionic copolymers are those which contain 80-98% by weight of optionally substituted acrylic acid and 2-20% by weight of C 12 -C 30 fatty alcohol methacrylic acid esters and can be crosslinked as monomers. Such connections are e.g. B. the commercial products Pemulen ® .
  • Amphoteric polymers are understood to mean both those polymers which contain both free amino groups and free -COOH or SO 3 H groups in the molecule and are capable of forming internal salts, and also zwitterionic polymers which contain quaternary ammonium groups and -COO "in the molecule. - or -SO 3 " groups or -COOH or SO 3 H groups.
  • amphoteric polymer is the acrylic resin commercially available as Amphomer ®, which is a copolymer of tert-butylaminoethyl methacrylate, N- (1, 1,3,3-tetramethylbutyl) acrylamide and two or more monomers from the group consisting of acrylic acid, methacrylic acid and their esters.
  • Amphomer ® is a copolymer of tert-butylaminoethyl methacrylate, N- (1, 1,3,3-tetramethylbutyl) acrylamide and two or more monomers from the group consisting of acrylic acid, methacrylic acid and their esters.
  • the agents according to the invention can furthermore contain nonionic polymers.
  • Suitable nonionic polymers are, for example:
  • suitable cationic polymers are, for example, polysiloxanes having quaternary groups, such as the commercial products Q2-7224 (Dow Corning), Dow Corning ® 929 Emulsion, SM-2059 (General Electric), SLM-55067 (Wacker) and Abil ® - Quat 3270 and 3272 (Th. Goldschmidt), and the polymers known under the names Polyquatemium-2, Polyquaternium-17, Polyquaternium-18 and Polyquaternium-27 with quaternary nitrogen atoms in the main polymer chain.
  • polysiloxanes having quaternary groups such as the commercial products Q2-7224 (Dow Corning), Dow Corning ® 929 Emulsion, SM-2059 (General Electric), SLM-55067 (Wacker) and Abil ® - Quat 3270 and 3272 (Th. Goldschmidt)
  • a preferred cationic polymer according to the invention is the, if desired crosslinked, poly (methacryloyloxyethyltrimethylammonium chloride) with the INCI name Polyquatemium-37.
  • the crosslinking can be carried out with the aid of polyolefinically unsaturated compounds, for example divinylbenzene, tetraallyloxyethane, methylene bisacrylamide, diallyl ether, polyallyl polyglyceryl ether or allyl ethers of sugars or sugar derivatives such as erythritol, pentaerythritol, arabitol, mannitol, sorbitol, sucrose or glucose.
  • Methylene bisacrylamide is a preferred crosslinking agent.
  • Polyquatium-37 is preferably used in the form of a non-aqueous polymer dispersion. Such polymer dispersions are commercially available under the names Salcare ® SC 95 and Salcare ® SC 96.
  • Copolymers of methacryloyloxyethyltrimethylammonium chloride and non-ionic monomers, acrylamide, methacrylamide, acrylic acid-C 1-4 -alkyl and preferably methacrylic acid-C M alkyl esters, which may be crosslinked, optionally, are commercially available under the name Salcare ® SC 92nd
  • the cosmetic compositions used to foam the sponges according to the invention contain several, in particular two different polymers of the same charge and / or each contain an ionic and an amphoteric and / or nonionic polymer.
  • the compositions used for foaming the sponges according to the invention contain ⁇ -hydroxycarboxylic acids.
  • the ⁇ -hydroxycarboxylic acids are selected from glycolic acid, lactic acid, methyllactic acid, 2-hydroxybutanoic acid, 2-hydroxypentanoic acid, 2-hydroxyhexanoic acid, 2-hydroxyheptanoic acid,
  • the ⁇ -hydroxycarboxylic acids are used in amounts of 0.01-10% by weight, preferably 0.1-5% by weight and particularly preferably 1-3% by weight, in each case based on the foams used for foaming the sponges according to the invention Composition used.
  • Active substances or care substances suitable according to the invention are also vitamins, provitamins and vitamin precursors of groups B, C and H and their derivatives.
  • the vitamin B group or the vitamin B complex include u. a.
  • Vitamin B 2 (riboflavin)
  • Vitamin B 3 The compounds nicotinic acid and nicotinamide (niacinamide) are often listed under this name.
  • the nico Tinklad which is preferably contained in amounts of 0.05 to 1 wt .-%, based on the cosmetic composition used to foam the sponges according to the invention.
  • Vitamin B 5 pantothenic acid and panthenol.
  • Panthenol is preferably used.
  • Derivatives of panthenol which can be used according to the invention are, in particular, the esters and ethers of panthenol and cationically derivatized panthenols.
  • derivatives of 2-furanone with the general structural formula (I) can also be used.
  • the 2-furanone derivatives in which the substituents R 1 to R 6 independently of one another are a hydrogen atom, a hydroxyl radical, a methyl, methoxy, aminomethyl or hydroxymethyl radical, a saturated or mono- or di-unsaturated, linear or branched C 2 -C 4 - hydrocarbon residue, a saturated or mono- or di-unsaturated, branched or linear mono-, di- or trihydroxy-C 2 -C 4 - hydrocarbon residue or a saturated or mono- or di-unsaturated, branched or linear mono- , Di- or triamino-C 2 -C 4 - represent hydrocarbon radical.
  • the substituents R 1 to R 6 independently of one another are a hydrogen atom, a hydroxyl radical, a methyl, methoxy, aminomethyl or hydroxymethyl radical, a saturated or mono- or di-unsaturated, linear or branched C 2 -C 4 - hydrocarbon residue, a saturated or mono- or di-
  • Particularly preferred derivatives are the commercially available substances dihydro-3-hydroxy-4,4-dimethyl-2 (3H) -furanone with the common name pantolactone (Merck), 4-hydroxymethyl- ⁇ -butyrolactone (Merck), 3.3 -Dimethyl-2-hydroxy- ⁇ -butyrolactone (Aldrich) and 2,5-dihydro-5-methoxy-2-furanone (Merck), all stereoisomers being expressly included.
  • the 2-furanone derivative which is extremely preferred according to the invention is pantolactone (dihydro-3-hydroxy-4,4-dimethyl-2 (3H) -furanone), where in formula (I) R 1 is a hydroxyl group, R 2 is a hydrogen atom, R 3 and R 4 represent a methyl group and R 5 and R 6 represent a hydrogen atom.
  • the stereoisomer (R) - pantolactone is formed when pantothenic acid is broken down.
  • the above-mentioned compounds of the vitamin B 5 type and the 2-furanone derivatives are preferably in a total amount of 0.05 to 10% by weight, particularly preferably 0.1 to 5% by weight, in each case based on those for foaming the inventive Sponges used composition included.
  • Vitamin B 6 pyridoxine as well as pyridoxamine and pyridoxal.
  • Vitamin B 7 also known as vitamin H or "skin vitamin”.
  • Biotin is preferably present in amounts of 0.0001 to 1.0% by weight, in particular 0.001 to 0.01% by weight, in each case based on the composition used to foam the sponges according to the invention.
  • Vitamin C ascorbic acid
  • Vitamin C or its derivatives are preferably used in amounts of 0.1 to 3% by weight, based on the composition used to foam the sponges according to the invention.
  • Use in combination with tocopherols may also be preferred.
  • Preferred vitamins, provitamins and vitamin precursors from groups B, C and H are panthenol and its derivatives, pantolactone, nicotinamide, ascorbyl palmitate, sodium ascorbyl phosphate, magnesium ascorbyl phosphate and biotin.
  • the plant extracts suitable according to the invention are selected from the divisible production tissue of the plants (Meristem), green tea (Camellia sinensis), witch hazel, chamomile, marigold, pansy, peaonia, horse chestnut, sage, willow bark, cinnamon tree (cinnamon tree), chrysanthemums, oak bark, nettle , Hops, burdock root, horsetail, hawthorn, linden flowers, almonds, spruce needles, sandalwood, juniper, coconut, kiwi, guava, lime, mango, apricot, wheat, melon, orange, grapefruit, avocado, rosemary, birch, beech sprouts, mallow sprout , Yarrow, quendel, thyme, lemon balm, hake, marshmallow (Althaea), mallow (Malva sylvestris), violet, leaves of black currant, coltsfoot, quintuple, ginseng, ginger root, sweet potato
  • the algae extracts used according to the invention come from green algae, brown algae, red algae or blue-green algae (cyanobacteria).
  • the algae used for the extraction can be of natural origin as well as obtained through biotechnological processes and, if desired, can be changed compared to the natural form.
  • the organisms can be changed genetically, by breeding or by cultivation in media enriched with selected nutrients.
  • Preferred algae extracts come from seaweed, blue-green algae, from the green algae Codium tomentosum and from the brown algae Fucus vesiculus.
  • a particularly preferred algae extract comes from blue algae of the Spirulina species, which were cultivated in a magnesium-enriched medium. Extracts from microorganisms, eg. B. from yeasts, preferably from baker's yeast.
  • the extracts from spirulina, baker's yeast, green tea (Cameilia sinensis), meristem, witch hazel, apricot, marigold, guava, sweet potato, lime, mango, kiwi, cucumber, mallow, marshmallow, violet, olive tree leaves and citrus sinensis are particularly preferred.
  • the agents according to the invention can also contain mixtures of several, in particular two, different plant extracts.
  • Suitable antiperspirant active ingredients according to the invention are water-soluble astringent metallic salts, in particular inorganic and organic salts of aluminum, zirconium and zinc or any mixtures of these salts.
  • alum KAI (SO 4 ) 2 • 12 H 2 O
  • water solubility is understood to mean a solubility of at least 5 g of active substance per 100 g of solution at 20 ° C.
  • the antiperspirant active ingredients are used as aqueous solutions. According to the invention, they are contained in an amount of active substance of 1 to 40% by weight, preferably 5 to 30% by weight and in particular 10 to 25% by weight, based on the composition used to foam the sponges according to the invention.
  • the composition contains an astringent aluminum salt, in particular aluminum chlorohydrate, and / or an aluminum-zirconium compound.
  • Aluminum chlorohydrates are, for example sold in powder form as Micro Dry ® Ultrafine by Reheis, in the form of an aqueous solution as Locron ® L by Clariant, as Chlorhydrol ® and in activated form as Reach ® 501 by Reheis.
  • An aluminum sesquichlorohydrate from Reheis is available under the name Reach ® 301.
  • Suitable as deodorants according to the invention are fragrances, antimicrobial, antibacterial or germ-inhibiting substances, enzyme-inhibiting substances, antioxidants and odor adsorbents.
  • Suitable antimicrobial, antibacterial or germ-inhibiting substances are in particular organohalogen compounds and halides, quaternary ammonium compounds, a number of plant extracts and zinc compounds.
  • Halogenated phenol derivatives such as. B. hexachlorophene or Irgasan DP 300 (triclosan, 2,4,4'-trichloro-2'-hydroxydiphenyl ether), 3,4,4'-trichlorocarbonilide, chlorhexidine (1,1'-hexamethylene-bis- [5- (4th -chlorophenyl)] - biguanide), chlorhexidine gluconate, benzalkonium halide, bromochlorophene, dichlorophene, chlorothymol, chloroxylenol, hexachlorophen, cloflucarban, dichloro-m-xylenol, dequalinium chloride, domiphenbromide, ammonium phenol sulfonate,
  • Plant extracts with an antimicrobial effect which are particularly preferred according to the invention are selected from water- and oil-soluble extracts of the leaves of the black currant, chamomile flowers, cloves, burdock root, pansy, ribwort, citrus sinensis and green tea (Camellia sinensis) and from terpene alcohols, e.g. B. Farnesol, and components of linden blossom oil.
  • phenol phenoxyethanol, disodium dihydroxyethylsulfosuccinylundecylenate, sodium bicarbonate, zinc lactate, zinc phenol sulfonate and sodium phenol sulfonate, ketoglutaric acid, chlorophyllin-copper complexes, glycerol monoalkyl ether and carboxylic acid esters of mono-, di- and tri-monolinoclycerol glycerol.
  • deodorant active substances Even weaker-acting antimicrobial substances, which, however, have a specific effect against the gram-positive germs responsible for the decomposition of sweat, can be used as deodorant active substances.
  • These include many ethereal ones Oils such as B. clove oil (eugenol), mint oil (menthol) or thyme oil (thymol) and terpene alcohols such as. B. Farnesol.
  • Aromatic alcohols such as. B. benzyl alcohol, 2-phenylethanol or 2-phenoxyethanol can be used as deodorant active ingredients.
  • antibacterial deodorants are lantibiotics, glycoglycerolipids, sphingolipids (ceramides), sterols and other active ingredients that inhibit bacterial adhesion to the skin, e.g. B. glycosidases, lipases, proteases, carbohydrates, di- and oligosaccharide fatty acid esters and alkylated mono- and oligosaccharides. Long-chain diols, e.g. B.
  • Deodorising substances which inhibit ester-splitting enzymes and in this way counteract the decomposition of perspiration are particularly deodorising as enzyme-inhibiting substances.
  • Antioxidative substances can counteract the oxidative decomposition of the welding components and thus inhibit the development of odors.
  • Suitable antioxidants are carotenoids, carotenes (eg ⁇ -carotene, ⁇ -carotene, lycopene) and their derivatives, lipoic acid and their derivatives (eg dihydroliponic acid), thio compounds, eg. B.
  • thioglycerin thiosorbitol, thioglycolic acid, thioredoxin, glutathione, cysteine, cystine, cystamine and their esters and their salts, dilaurylthiodipropionate, distearylthiodipropionate, thiodipropionic acid and their derivatives as well as sulfoximine compounds in very low tolerable dosages / kg ⁇ mol / kg), furthermore metal chelators (e.g. ⁇ -hydroxyfatty acids, EDTA, EGTA, phytic acid, lactoferrin), humic acids, bile acid, bile extracts, gallic acid esters (e.g.
  • ferulic acid ethyl ferulate, caffeic acid
  • kojic acid chitosan glycolate and salicylate
  • butylated hydroxytoluene butylated hydroxyanisole
  • nordihydrogu ajakarzarzäure Nordi- hydroguajaretklare
  • trihydroxybutyrophenon uric acid and its derivatives, mannose and their derivatives, selenium and selenium derivatives (e.g. selenium methionine), stilbenes and stilbene derivatives (e.g. stiibenoxide, trans-stilbene oxide).
  • suitable derivatives salts, esters, sugars, nucleotides, nucleosides, peptides and lipids
  • suitable derivatives e.g. tea tree oil, rosemary extract and rosemary acid
  • plant extracts e.g. tea tree oil, rosemary extract and rosemary acid
  • Preferred lipophilic, oil-soluble antioxidants from this group are gallic acid esters, flavonoids and carotenoids, and butylated hydroxytoluene / anisole.
  • Preferred water-soluble antioxidants are tannins, especially those of vegetable origin.
  • the total amount of the antioxidants is 0.001-10% by weight, preferably 0.05-5% by weight and in particular 0.05-2% by weight, in each case based on the composition used to foam the sponges according to the invention.
  • the following substances can be used as odor absorbers: zinc ricinoleate, cyclodextrin and its derivatives, e.g. Hydroxypropyl- ⁇ -cyclodextrin, furthermore oxides such as magnesium oxide or zinc oxide, the oxides not being compatible with aluminum chlorohydrate, furthermore starch and starch derivatives, silicas, which may be modified, zeolites, talc and synthetic polymers, e.g. Nylon.
  • Complexing substances can support the deodorizing effect by stably complexing the oxidative catalytic heavy metal ions (eg iron or copper).
  • Suitable complexing agents are e.g. B. the salts of ethylenediaminetetraacetic acid or nitrilotriacetic acid and the salts of 1-hydroxyethane-1,1-diphosphonic acid.
  • silicas silicas, natural and synthetic silicates, aluminosilicates, kaolin, talc and apatites, which can be modified with aqueous carboxylic acids with 2 to 3 carbon atoms.
  • both colored and colorless pigments can be used according to the invention.
  • the pigments are selected from the oxides of titanium, iron, zinc, zirconium, magnesium, cerium and bismuth, which can, if desired, be surface-modified, boron nitride particles, water-insoluble pearlescent pigments and water-insoluble organic pigments. Some of the pigments mentioned below also serve as UV absorbers.
  • Particularly preferred colored pigments are selected from the iron oxides with the color index numbers Cl 77491 (red iron oxide), Cl 77492 (yellow iron oxide hydrate) and Cl 77499 (black iron oxide), from Cl 77891 (titanium dioxide) and carbon black.
  • color pigments are selected from Cl 15510, Cl 15585, Cl 15850, Cl 15985, Cl 45170, Cl 45370, Cl 45380, Cl 45425, Cl 45430, Cl 73360, and Cl 75470.
  • the preferred pigments are selected from the oxides of titanium , Zinc, zircon and iron.
  • the preferred inorganic particle substances are hydrophilic or amphiphilic. They can advantageously be surface-coated, in particular surface-treated ("coated"). Examples include titanium dioxide pigments coated with aluminum stearate (MT 100 T commercial product from Tayca), zinc oxide coated with dimethylpolysiloxane (Dimethicone), boron nitride coated with Dimethicone ( Tres BN ® UHP 1106 from Carborundum), titanium dioxide coated with a mixture of dimethylpolysiloxane and silica gel (Simethicone) and aluminum oxide hydrate (Alumina) (Eusolex ® T 2000 from Merck), titanium dioxide coated with octylsilanol or spherical polyalkylsesquisiloxane particles (Aerosil ® R972 ® 200V from Degussa).
  • MT 100 T commercial product from Tayca
  • Dimethicone zinc oxide coated with dimethylpolysiloxane
  • the organic UV filters used according to the invention are selected from the derivatives of dibenzoylmethane, cinnamic acid esters, diphenylacrylic acid esters, benzophenone, camphor, p-aminobenzoic acid esters, o-aminobenzoic acid esters, salicylic acid esters, benzimidazoles, 1, 3,5-triazines, monomeric and oligomeric 4,4- Diarylbutadienecarboxylic acid esters and carboxamides, ketotricyclo (5.2.1.0) decane, benzalmalonic acid esters and any mixtures of the components mentioned.
  • the organic UV filters can be oil-soluble or water-soluble.
  • oil-soluble UV filters are 1- (4-tert-butylphenyl) - 3- (4'methoxyphenyl) propane-1,3-dione (Parsol ® 1789), 1-phenyl-3- (4'-isopropylphenyl ) - propane-1, 3-dione, 3- (4'-methylbenzylidene) -D, L-camphor, 4- (dimethylamino) -benzoic acid- 2-ethylhexyl ester, 4- (dimethylamino) benzoic acid-2-octyl ester, 4- (Dimethylamino) - amyl benzoate, 2-ethylhexyl 4-methoxycinnamate, propyl 4-methoxycinnamate, isopentyl 4-methoxycinnamate, 2-ethylhexyl 2-cyano-3,3-phenylcinnamate (octocrylene), 2-ethylhexyl
  • Preferred water-soluble UV filters are 2-phenylbenzimidazole-5-sulfonic acid and its alkali metal, alkaline earth metal, ammonium, alkylammonium, alkanolammonium and glucammonium salts, sulfonic acid derivatives of benzophenones, preferably 2-hydroxy-4-methoxybenzophenone-5 -sulfonic acid and its salts, sulfonic acid derivatives of 3-benzylidene camphor, such as.
  • the organic UV filters are present in amounts of 0.1-20% by weight, preferably 1-15% by weight and particularly preferably 2-10% by weight, in each case based on the composition used to foam the sponges according to the invention contain.
  • the liquid, water-containing phase can also contain cosmetic abrasives, selected from polymer particles and vegetable abrasives, which, if desired, can be coated with fatty substances.
  • Suitable polymeric abrasives are selected from optionally modified starches and starch derivatives, crystalline cellulose, cellulose powders, lactoglobulin derivatives, ground plant parts such as almond bran or wheat bran, hardened jojoba oil (jojoba beads), polymer particles made from polyolefins, polycarbonates, polyurethanes, or polyacrylates, polyacrylates, polyacrylates, polyacrylates (Meth) acrylate-vinylidene copolymers, which can be crosslinked, polyesters, polyamides, polystyrenes, Teflon or silicones, and micro- or millicapsules, the petrochemical polymers and / or biopolymers such as gelatin, pectin, vegetable gums, alginates and carrageenan and optionally Contain cosmetic active
  • Abrasives with average diameters of 90-600 ⁇ m are preferred.
  • Almond bran, wheat bran, hardened jojoba oil and polymer beads, in particular polyethylene beads, are particularly preferably used as peeling substances.
  • Micro- or millicapsules containing active ingredients are also particularly preferred.
  • the commercial capsules are often referred to as aqueous polymer dispersion before, for example, the particularly preferred Millicapsules ® Lipotec SA (INCI name: Aqua, Tocopheryl Acetate, Glycerine, carbomer, Sebacic Acid, agar, Green colourant, Alginic Acid).
  • compositions used for foaming the sponges according to the invention can contain dyes and oxidation dye (preliminary product) for dyeing keratin fibers.
  • oxidation dye preliminary product
  • the composition of the colorants or tints is not subject to any fundamental restrictions. Can be used as an oxidation dye (intermediate)
  • Oxidation dye precursors of the developer and coupler type
  • Primary aromatic amines with a further free or substituted hydroxy or amino group in the para or ortho position, diaminopyridine derivatives, heterocyclic hydrazones, 4-aminopyrazole derivatives and 2,4,5,6-tetraaminopyrimidine are usually used as oxidation dye precursors of the developer type and its derivatives used.
  • Suitable developer components are, for example, p-phenylenediamine, p-toluenediamine, p-aminophenol, o-aminophenol, 1- (2'-hydroxyethyl) -2,5-diaminobenzene, N, N-bis (2-hydroxyethyl) -p-phenylenediamine, 2- (2,5-diaminophenoxy) ethanol, 4-amino-3-methylphenol, 2,4,5,6-tetraaminopyrimidine, 2-hydroxy-4,5,6-triaminopyrimidine, 4-hydroxy -2,5,6-triaminopyrimidine, 2,4-dihydroxy-5,6-diaminopyrimidine, 2-dimethylamino-4,5,6-triaminopyrimidine, 2-hydroxymethylamino-4-aminophenol, bis- (4-aminophenyl) amine, 4-amino-3-fluorophenol, 2-aminomethyl-4-aminophenol, 2-
  • Particularly advantageous developer components are p-phenylenediamine, p-toluenediamine, p-aminophenol, 1- (2'-hydroxyethyl) -2,5-diaminobenzene, 4-amino-3-methylphenol, 2-aminomethyl-4-aminophenol, 2,4 , 5,6-tetraaminopyrimidine, 2-hydroxy-4,5,6-triaminopyrimidine and 4-hydroxy-2,5,6-triaminopyrimidine.
  • M-Phenylenediamine derivatives, naphthols, resorcinol and resorcinol derivatives, pyrazolones and m-aminophenol derivatives are generally used as oxidation dye precursors of the coupler type.
  • coupler components are m-aminophenol and its derivatives such as 5-amino-2-methylphenol, 5- (3-hydroxypropylamino) -2-methylphenol, 3-amino-2-chloro-6-methylphenol, 2-hydroxy -4-aminophenoxyethanol, 2,6-dimethyl-3-aminophenol, 3-trifluoroacetylamino-2-chloro-6-methylphenol, 5-amino-4-chloro-2-methylphenol, 5-amino-4-methoxy-2-methylphenol , 5- (2'-Hydroxyethyl) amino-2-methylphenol, 3- (diethylamino) phenol, N-cyclopentyl-3-aminophenol, 1,3-dihydroxy-5- (methylamino) -benzene, 3- (ethyl - amino) -4-methylphenol and 2,4-dichloro-3-aminophenol,
  • Di- or trihydroxybenzene derivatives such as resorcinol, resorcinol monomethyl ether, 2-methylresorcinol, 5-methylresorcinol, 2,5-dimethylresorcinol, 2-chlororesorcinol, 4-chlororesorcinol, pyrogallol and 1, 2,4-trihydroxybenzene,
  • Pyridine derivatives such as 2,6-dihydroxypyridine, 2-amino-3-hydroxypyridine, 2-amino-5-chloro-3-hydroxypyridine, 3-amino-2-methylamino-6-methoxypyridine, 2,6-dihydroxy-3, 4-dimethylpyridine, 2,6-dihydroxy-4-methylpyridine, 2,6-diaminopyridine, 2,3-diamino-6-methoxypyridine and 3,5-diamino-2,6-dimethoxypyridine, naphthalene derivatives such as 1-naphthol, 2 -Methyl-1-naphthol, 2-hydroxy-methyl-1-naphthol, 2-hydroxyethyl-1-naphthol, 1,5-dihydroxynaphthalene, 1,6-dihydroxy-naphthalene, 1, 7-dihydroxynaphthalene, 1, 8-dihydroxynaphthalene , 2,7-Dihydroxy-naphthalene
  • Morpholine derivatives such as 6-hydroxybenzomorpholine and 6-amino-benzomorpholine,
  • Pyrazole derivatives such as 1-phenyl-3-methylpyrazol-5-one, indole derivatives such as 4-hydroxyindole, 6-hydroxyindole and 7-hydroxyindole, Methylenedioxybenzene derivatives such as 1-hydroxy-3,4-methylenedioxybenzene, 1-amino-3,4-methylenedioxybenzene and 1- (2'-hydroxyethyl) amino-3,4-methylenedioxybenzene,
  • coupler components are 1-naphthol, 1,5-, 2,7- and 1,7-dihydroxynaphthalene, 3-aminophenol, 5-amino-2-methylphenol, 2-amino-3-hydroxypyridine, resorcinol, 4-chlororesorcinol, 2-chloro-6-methyl-3-aminophenol, 2-methylresorcinol, 5-methylresorcinol, 2,5-dimethylresorcinol and 2,6-dihydroxy-3,4-dimethylpyridine.
  • Direct dyes are usually nitrophenylenediamines, nitroaminophenols, azo dyes, anthraquinones or indophenols.
  • Particularly suitable direct dyes are those under the international names or trade names HO Yellow 2, HC Yellow 4, HO Yellow 5, HC Yellow 6, Basic Yellow 57, Disperse Orange 3, HO Red 3, HC Red BN, Basic Red 76, HC Blue 2, HC Blue 12, Disperse Blue 3, Basic Blue 99, HC Violet 1, Disperse Violet 1, Disperse Violet 4, Disperse Black 9, Basic Brown 16 and Basic Brown 17 known compounds as well as 1, 4-bis- (ß- hydroxyethyl) amino-2-nitrobenzene, 4-amino-2-nitrodiphenylamine-2'-carboxylic acid, 6-nitro-1, 2,3,4-tetrahydroquinoxaline, hydroxyethyl-2-nitro-toluidine, picramic acid, 2- Amino-6-chloro-4-nitrophenol, 4-ethylamino-3-nitrobenzo
  • Directly occurring dyes found in nature are contained, for example, in henna red, henna neutral, henna black, chamomile flowers, sandalwood, black tea, rotten tree bark, sage, blue wood, madder root, catechu, sedre and alkanna root.
  • indoles and indolines and their physiologically tolerable salts are used as precursors of nature-analogous dyes.
  • Those indoles and indolines are preferably used which have at least one hydroxyl or amino group, preferably as a substituent on the six-membered ring.
  • These groups can carry further substituents, e.g. B. in the form of etherification or esterification of the hydroxy group or an alkylation of the amino group.
  • N-methyl-5,6-dihydroxyindoline N-ethyl-5,6-dihydroxyindoline, N-propyl-5,6-dihydroxyindoline, N-butyl-5,6-dihydroxyindoline and especially 5 6-dihydroxyindoline and N-methyl-5,6-dihydroxyindole, N-ethyl-5,6-dihydroxyindole, N-propyl-5,6-dihydroxyindole and N-butyl-5,6-dihydroxyindole. 5,6-Dihydroxyindole is particularly preferred.
  • the indoline and indole derivatives can be used in the dye-containing compositions used to foam the sponges according to the invention both as free bases and in the form of their physiologically tolerable salts with inorganic or organic acids, for.
  • B. the hydrochloride, the sulfates and hydrobromides can be used.
  • Oxidizing and reducing agents which are suitable for use on the human body can also be used according to the invention.
  • oxidizing agents serve on the one hand to produce permanent hair coloring with the aid of oxidation dye precursors of the developer and coupler type by oxidatively coupling both types of precursors with one another.
  • the hair is either treated first with the oxidation dye precursors and then with the oxidizing agent, or the oxidation dye precursors and the oxidizing agent are mixed directly before use and then applied to the hair.
  • oxidizing agents are used to fix permanent hair deformation (perm) after the reductive wave treatment of the hair.
  • Persulfates, chlorites, sodium bromate, potassium bromate and in particular hydrogen peroxide or its addition products with urea, melamine and with sodium borate are suitable as oxidizing agents.
  • the particularly preferred hydrogen peroxide is used together with the stabilizers customary for stabilizing aqueous hydrogen peroxide preparations.
  • the pH of such aqueous H 2 O 2 preparations which usually contain about 0.5 to 15% by weight, usually about 0.5 to 3% by weight, of H 2 O 2 ready for use, is preferably included 2 to 6, in particular 2 to 4; it is adjusted by acids, preferably phosphoric acid, phosphonic acids and / or dipicolinic acid.
  • Bromate-based fixatives usually contain the bromates in concentrations of 1 to 10% by weight, the The pH of the solutions is adjusted to 4 to 7. It is furthermore possible to carry out the oxidation with the aid of enzymes, the enzymes being used both for producing oxidizing per compounds and for enhancing the action of a small amount of oxidizing agents present, or else enzymes which use electrons from suitable Transfer developer components (reducing agents) to atmospheric oxygen.
  • Oxidases such as tyrosinase, ascorbate oxidase and laccase are preferred, but also glucose oxidase, uricase or pyruvate oxidase.
  • Reducing agents are mainly used in cosmetics for permanent hair shaping, in that they are applied to the hair that has been twisted on curlers and there cause cleavage of the keratin disulfide bridges.
  • Suitable reducing agents are in particular thioglycolic acid or its salts or esters.
  • cosmetic or dermatological active ingredients with sebum-regulating, skin-calming, anti-inflammatory, astringent or blood circulation-promoting effect can be used according to the invention.
  • Sebum-regulating active ingredients are selected according to the invention particularly preferably from water- and oil-soluble extracts from witch hazel, burdock root and nettle, cinnamon tree extract (e.g. Sepicontrol ® A5 from Seppic), chrysanthemum extract (e.g. Laricyl ® from Laboratoires Serobi unanimouss) and from commercially available Active ingredient mixtures, e.g. B.
  • Asebiol ® BT 2 (INCI: Aqua, Hydrolyzed Yeast Protein, Pyridoxine, Niacinamide, glycerol, panthenol, allantoin, biotin) from the company Laboratoires Serobiiquess and antiobesity factor ® COS-218/2-A (from Cosmetochem, INCI: Aqua, cetyl -PCA, PEG-8 isolauryl thioether, PCA, cetyl alcohol).
  • Anti-acne active ingredients for.
  • Skin-calming active ingredients are particularly preferably selected according to the invention from allantoin, ⁇ -bisabolol, deoxy sugars and deoxy sugar building blocks containing poiysaccharides.
  • the preferred deoxy sugars according to the invention are L (-) - fucose and L (+) - rhamnose. Fucose comes e.g. B. before as a building block of poiysaccharides, which can be isolated from marine brown algae (e.g. Fucus vesiculosus), rhamnose is a polysaccharide building block of arabic acid in gum arabic. B.
  • Anti-inflammatory agents are selected according to the invention particularly preferably from ⁇ -bisabolol and the water and oil-soluble extracts from ivy, arnica, Camellia sinensis (green tea), witch hazel, Hibiscus sabdariffa, St. John's wort, chamomile (Matricaria chamomilla), Ruscus asculeatus, Malva silvestris, Schacht Yarrow (Achillea millefolium).
  • astringent active ingredients are particularly preferably selected from water- and oil-soluble extracts from witch hazel, willow bark, oak bark and sage.
  • the blood circulation-promoting substances are selected from nicotinic acid derivatives with vasodilatory effect, capsaicin, extracts from chili peppers (red pepper), rutin and rutin derivatives, caffeine and horse chestnut extract as well as mixtures thereof.
  • a particularly preferred circulation-promoting nicotinic acid derivative according to the invention is vitamin E nicotinate (tocopherol nicotinate), preferably in amounts of 0.1-2% by weight, based on the composition used to foam the sponges according to the invention.
  • antioxidants and / or UV absorbers can preferably be added.
  • Particularly suitable antioxidants and / or UV absorbers are tetrabutyl pentaerythrityl hydroxyhydrocinnamate (INCI name), also as neopentanetetrayl tetrakis (3,5-di-tert-butyl-4-hydroxyhydrocinnamate) or
  • Tetrakis [methylene- (3,5-di-tert-butyl-4-hydroxyhydrocinnamate)] methanes are known and commercially available e.g. B. available under the product name Tinogard TT (Ciba), 2-tert-butyl-6- (5-chloro-2H-benzotriazol-2-yl) -p-cresol (INCI name: Bumetrizole), commercially z. B.
  • Tinogard AS Ciba
  • Tinogard HS Tinogard H Liquid
  • Tinogard TL Tinogard TL
  • the compositions used for foaming the sponges according to the invention can be water-soluble Contain polyols.
  • these include water-soluble diols, triols and higher alcohols, polyglycerols, polyethylene glycols as well as mono- and disaccharides.
  • water solubility means that at least 5% by weight of the alcohol clearly dissolves at 20 ° C. or - in the case of long-chain or polymeric alcohols - can be brought into solution by heating the solution to 50-60 ° C.
  • the diols are C 2 -C 12 diols, in particular 1, 2-propylene glycol, butylene glycols such as.
  • Glycerol and polyglycerols, in particular diglycerol and triglycerol, 1,2,6-hexanetriol, and also polyethylene glycol (PEG) PEG-400, PEG-600, PEG-1000, PEG-1550, PEG-3000 and PEG are also particularly preferred -4000.
  • Suitable monosaccharides are e.g. B. glucose, fructose, galactose, arabinose, ribose, xylose, lyxose, allose, old rose, mannose, gulose, idose and talose, the deoxy sugar fucose and rhamnose and amino sugar such as. B. glucosamine or galactosamine. Glucose, fructose, galactose, arabinose and fucose are preferred; Glucose is particularly preferred.
  • Suitable oligosaccharides are composed of two to ten monosaccharide units, e.g. B. sucrose, lactose or trehalose. A particularly preferred oligosaccharide is sucrose. The use of honey, which predominantly contains glucose and sucrose, is also particularly preferred.
  • the compositions used for foaming the sponges according to the invention can contain vitamins, provitamins and vitamin precursors of groups A, E and F and also their derivatives.
  • the group of substances called vitamin A includes retinol (vitamin A.,) and 3,4-didehydroretinol (vitamin A 2 ).
  • the ß-carotene is the provitamin of retinol.
  • vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as palmitate and acetate are suitable as vitamin A components.
  • the vitamin A component is preferably present in amounts of 0.05-1% by weight, based on the cosmetic composition used to foam the sponges according to the invention.
  • the group of substances referred to as vitamin E includes tocopherols, in particular ⁇ -tocopherol, and tocopherol derivatives.
  • Tocopherol and its derivatives, including in particular the esters such as the acetate, the nicotinate, the phosphate and the succinate, are preferably present in amounts of 0.05-1% by weight, based on the composition used to foam the sponges according to the invention ,
  • vitamin F is usually understood to mean essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.
  • compositions used for foaming the sponges according to the invention can contain both vegetable and animal proteins and protein hydrolyzates.
  • Animal protein hydrolyzates are e.g. B. elastin, collagen, keratin, silk and milk protein protein hydrolyzates, which may also be in the form of salts.
  • Vegetable protein hydrolyzates e.g. B. soy, wheat, almond, pea, potato and rice protein hydrolyzates.
  • Corresponding commercial products are e.g. B. DiaMin ® (Diamalt), Gluadin ® (Cognis), and Lexein ® (Inolex).
  • Amino acid mixtures or individual amino acids such as arginine, lysine, histidine, glycine, pyrrolidine-2-carboxylic acid or pyrroglutamic acid can furthermore advantageously be used according to the invention. It is also possible to use derivatives of protein hydrolyzates, e.g. B. in the form of their fatty acid condensation products. Corresponding commercial products are e.g. B. Lamepon ® (Cognis), Gluadin ® (Cognis), Lexein ® (Inolex), Crolastin ® or Crotein ® (Croda).
  • Cationized protein hydrolyzates can also be used according to the invention, it being possible for the underlying protein hydrolyzate to come from animals, plants, marine life forms or biotechnologically obtained protein hydrolyzates.
  • Cationic protein hydrolyzates are preferred, the underlying protein portion of which has a molecular weight of 100 to 25,000 Daltons, preferably 250 to 5000 Daltons.
  • Cationic protein hydrolyzates also include quaternized amino acids and their mixtures.
  • the cationic protein hydrolyzates can also be further derivatized.
  • cationic protein hydrolyzates and derivatives used according to the invention Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Casein, Steardimonium Hydroxypropyl Hydrolyzed Collagen, Steardimonium Hydroxypropyl Hydrolyzed Hair Keratin, Lauryldimonium Hydroxypropyl Hydrolyzed Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Rice Protein, Cocodimonium Hydroxypropyl Hydrolysed Hydroxy, Cocodolyodium Hydroxypropyl Protein, Cocodolyiumhydroxypropyl Silk Amino Acids, Hydroxypropyl Arginine Lauryl / Myristyl Ether HCI, Hydroxypropyltrimonium Gelatin.
  • the cationic protein hydrolysates and derivatives based on plants are very particularly preferred.
  • the protein hydrolyzates and their derivatives are present in amounts of 0.01-10% by weight, preferably 0.1 to 5% by weight, particularly preferably 0.1 to 3% by weight, based in each case on those used to foam the inventive Sponges used composition included.
  • the carriers according to the invention can be used in a variety of ways.
  • Body cleansing sponge or used as a makeup remover is a body cleansing sponge or used as a makeup remover.
  • a further preferred embodiment of the invention contains the water-containing phase in the form of a 2-in-1 cleaning and care composition and can be used as a 2-in-1
  • Sponge can be used to clean and care for the face and / or body skin at the same time.
  • a further preferred embodiment of the invention contains the water-containing phase in the form of a skin care milk or lotion and can be used as a skin care sponge.
  • Water sponge can be used to clear, refresh and tone the face and / or body skin.
  • Sunscreens are used on the skin.
  • a further preferred embodiment of the invention contains the water-containing phase in the form of a peeling composition and can be used as a peeling sponge.
  • a further preferred embodiment of the invention contains the water-containing phase in the form of an antibacterial, anti-acne and disinfectant composition and can be used as an anti-acne sponge or as a disinfecting sponge.
  • Hair cleaning or conditioning sponge can be used.
  • Another preferred embodiment of the invention contains the water-containing phase in the form of an after-shave and can be used as an after-shave sponge.
  • Another preferred embodiment of the invention contains the water-containing phase in the form of a fragrant composition containing perfume oil or essential oil and can be used as a scented sponge.
  • Cover sponge can be used.
  • Another preferred embodiment of the invention contains the water-containing phase in the form of a hair dye or an oxidizing agent for bleaching the hair and can be used as a hair dye sponge, in particular for coloring selected strands of hair
  • Highlight sponge can be used.
  • Another preferred embodiment of the invention contains the aqueous phase in the form of an antiperspirant composition and can be used as an antiperspirant sponge.
  • Another preferred embodiment of the invention contains the water-containing phase in the form of a deodorant composition and can be used as a deodorant sponge.
  • Phases 1 and 3 are independently heated to 85 ° C. Phase 2 is added to phase 1. Phase 3 is then added to the mixture of phases 1 and 2 at 85 ° C. and homogenized for 5 minutes at this temperature. The emulsion is slowly cooled to 35 ° C., then phase 4 is added.
  • the emulsion prepared above is combined at room temperature with stirring with the prepolymer resin Hypol ® 2002 in a weight ratio of 65:35.
  • the mixture is stirred vigorously for 10 seconds and then poured into an open cylindrical shape with a diameter of 6 cm. In this form, the mixture is allowed to foam further and harden.
  • the foam body thus produced can be cut into slices or other suitable shapes after 2 hours.
  • the sponges shown in the other examples are produced in a corresponding manner.
  • Example 6 Clarifying toning sponge (toning pad)
  • Component amount [% by weight]
  • Component amount [% by weight]
  • Example 17 Sponge with developer dispersion for coloring cream from Example 16)
  • Component amount [% by weight]
  • the cream from Example 16 was first applied to the hair.
  • the developer dispersion from Example 17 was then applied. An intense red tint of the hair was obtained.
  • Component amount [% by weight]
  • this tint shampoo When this tint shampoo is applied to the hair, it gets a shiny, light blonde shade.

Abstract

L'invention concerne des éponges souples à pores minces, pourvues de liquides, qui sont à base de mousse polyuréthane. Ces éponges servent au traitement cosmétique et dermatologique de la peau, des cheveux, de la muqueuse et de l'appendice tégumentaire de la peau.
EP02737875A 2001-03-09 2002-03-05 Eponges cosmetiques Withdrawn EP1373348A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10111689 2001-03-09
DE10111689 2001-03-09
DE10208678A DE10208678A1 (de) 2001-03-09 2002-02-28 Kosmetische Schwämme
DE10208678 2002-02-28
PCT/EP2002/002371 WO2002085965A1 (fr) 2001-03-09 2002-03-05 Eponges cosmetiques

Publications (1)

Publication Number Publication Date
EP1373348A1 true EP1373348A1 (fr) 2004-01-02

Family

ID=26008744

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02737875A Withdrawn EP1373348A1 (fr) 2001-03-09 2002-03-05 Eponges cosmetiques

Country Status (3)

Country Link
US (1) US20040170670A1 (fr)
EP (1) EP1373348A1 (fr)
WO (1) WO2002085965A1 (fr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10234260A1 (de) * 2002-07-27 2004-02-05 Beiersdorf Ag Seifenhaltiges Reinigungsubstrat
DE10234259A1 (de) * 2002-07-27 2004-02-05 Beiersdorf Ag Tensidgetränktes Reinigungssubstrat
US7323438B2 (en) 2003-06-13 2008-01-29 Procter & Gamble Cleansing article with improved handleability
US20050025737A1 (en) * 2003-07-30 2005-02-03 Sebagh Jean Louis Compositions containing melon extracts
FR2863887B1 (fr) * 2003-12-23 2008-05-16 Jean Noel Thorel Procede d'innoformulation d'une base galenique biocompatible
DE102004032734A1 (de) * 2004-03-18 2005-10-06 Henkel Kgaa Präbiotisch wirksame Substanzen für Deodorantien
US20060094624A1 (en) * 2004-10-28 2006-05-04 Tom Carrothers Hard and soft surface cleaning agents
FR2881650B1 (fr) * 2005-02-09 2008-12-26 Oreal Article cosmetique de demaquillage
US20060210612A1 (en) * 2005-02-09 2006-09-21 L'oreal Make-up-removing article
WO2006113805A2 (fr) * 2005-04-19 2006-10-26 R.T. Vanderbilt Company, Inc. Stabilisant oxydatif et photo-oxydatif de mousses de polyuréthane d'application topique
US8173143B2 (en) * 2005-06-02 2012-05-08 Tecco Michelle A Personal skin care compositions containing anti-flammatory and anti-microbial agents
AU2007209923B2 (en) * 2006-01-31 2013-05-16 Covidien Lp Super soft foams
US20070253914A1 (en) * 2006-04-28 2007-11-01 Ha Robert B K Method of exfoliation
KR100887649B1 (ko) 2007-08-14 2009-03-12 (주)에스디생명공학 블랙헤드 제거 및 피지 조절을 위한 식물 추출물을 함유한팩 조성물
EP2095834B1 (fr) * 2008-02-21 2015-07-01 Semperit Aktiengesellschaft Holding Article prophylactique
US8895080B2 (en) * 2008-06-20 2014-11-25 Ocusoft, Inc. Compositions and kits for ocular treatment
EP2140994A1 (fr) * 2008-07-03 2010-01-06 Peter Irish Éponge, son procédé de fabrication, et appareil
CN102099015B (zh) * 2008-07-18 2015-05-06 拜奥莫达概念公司 释放活性成分的制品
KR101033288B1 (ko) 2008-09-16 2011-05-09 주식회사 티멤버스 머리카락 제거용구
US20100226948A1 (en) 2009-03-05 2010-09-09 Medicis Pharmaceutical Corporation Methods and compositions for treating acne
CN102439056B (zh) 2009-03-06 2016-01-13 生物高聚物技术有限公司 含有蛋白的乳液和粘合剂以及它们的制造与用途
EP2403886A2 (fr) 2009-03-06 2012-01-11 Biopolymer Technologies, Ltd. Mousses contenant des protéines, préparation et utilisation de celles-ci
US8440237B2 (en) 2009-04-27 2013-05-14 Mary Kay Inc. Botanical anti-acne formulations
GB0910657D0 (en) 2009-06-22 2009-08-05 Unilever Plc Antiperspirant compositions
MX2009013966A (es) * 2009-12-17 2011-06-16 Inst Potosino De Investigacion Cientifica Y Tecnologica A C Material de empaque para biofiltracion con base en poliuretano modificado con almidon, metodos para la manufactura del mismo y sistema de biofiltracion.
EP2377540A1 (fr) * 2010-03-31 2011-10-19 Hexal AG Timbre transdermique contenant du norgestimate 17-deacetyl
ES2619849T3 (es) * 2010-06-07 2017-06-27 Evertree Adhesivos que contienen proteína, y fabricación y uso de los mismos
KR101257628B1 (ko) * 2011-03-24 2013-04-29 (주)아모레퍼시픽 화장료 조성물이 함침된 발포 우레탄 폼을 포함하는 화장품
CA2832451A1 (fr) 2011-04-04 2012-10-11 The Procter & Gamble Company Article d'entretien menager
EP2744340A2 (fr) 2011-08-15 2014-06-25 The Procter and Gamble Company Méthodes de soins d'hygiène personnelle
SI2753633T1 (sl) * 2011-09-09 2017-05-31 Evertree Adhezivi, ki vsebujejo protein in njihova izdelava in uporaba
EP2760879B1 (fr) 2011-09-09 2023-06-14 Evertree Adhésifs contenant des protéines, leur fabrication et utilisation
US9138401B2 (en) 2011-12-19 2015-09-22 Mary Kay Inc. Combination of plant extracts to improve skin tone
KR20130116182A (ko) 2012-04-12 2013-10-23 (주)아모레퍼시픽 개선된 사용감을 가지는 발포 폼
WO2014020447A2 (fr) 2012-07-30 2014-02-06 Biopolymer Tecnologies, Ltd. Adhésifs protéiques contenant un composé d'anhydride, d'acide carboxylique et/ou de sel carboxylate et leur utilisation
MX360413B (es) 2013-06-27 2018-10-30 Procter & Gamble Composiciones conservantes para el cuidado personal.
DE102013212873A1 (de) * 2013-07-02 2015-01-08 Henkel Ag & Co. Kgaa Reinigungszusammensetzung mit hohem Fettsäuregehalt
US9868811B2 (en) 2013-08-02 2018-01-16 International Park Of Creativity Polyurethane biofoams derived from natural products and methods of making and using thereof
EP3116469B1 (fr) 2014-03-10 2018-10-03 Mary Kay, Inc. Compositions d'éclaircissement de la peau
SG11201705650VA (en) * 2015-01-12 2017-08-30 Lg Household & Health Care Ltd Cosmetic product comprising water-insoluble sponge impregnated with cosmetic composition having ultraviolet ray blocking function
WO2016167435A1 (fr) * 2015-04-13 2016-10-20 주식회사 엘지생활건강 Mousse de polyuréthane souple utilisant un polyol hydrocarboné et produit cosmétique la comprenant
KR101725803B1 (ko) * 2015-04-13 2017-04-11 주식회사 엘지생활건강 탄화수소 폴리올을 이용한 연질 폴리우레탄 폼 및 이를 포함하는 화장품
MX2018002476A (es) * 2015-08-31 2018-06-15 Cohera Medical Inc Adhesivo para reparacion de menisco.
KR101850882B1 (ko) * 2016-04-05 2018-05-23 주식회사 동우에너지소재 자당을 포함하는 폴리우레탄 필름 및 이를 이용한 화장용 도포구의 제조방법
KR101743610B1 (ko) * 2016-04-19 2017-06-16 주식회사 동우에이엘티 화장용 퍼프
CN108250727B (zh) * 2018-02-09 2020-08-14 纳琦环保科技有限公司 一种具有净化功能的聚合物泡沫材料的制备方法
PL238430B1 (pl) * 2018-03-20 2021-08-23 Politechnika Lodzka Kompozycja na piankę poliuretanową o właściwościach antybakteryjnych i przeciwgrzybicznych
PL239067B1 (pl) * 2018-03-20 2021-11-02 Politechnika Lodzka Kompozycja na piankę poliuretanową o właściwościach antybakteryjnych i przeciwgrzybicznych
FR3085274A1 (fr) * 2018-09-04 2020-03-06 Bassoni Sylvie "Agissant Au Nom Et Pour Le Compte De La Société Nomadsens En Cours De Formation" Composition cosmetique naturel, biologique et anhydre comprenant de la spiruline
CN109438966B (zh) * 2018-10-29 2021-08-27 叶友岳 一种高强度复合包装材料及其制备方法
DE102018221959A1 (de) * 2018-12-17 2020-06-18 Henkel Ag & Co. Kgaa Oxidationsfärbemittel in Rotnuancen mit verbesserter Echtheit und verbesserter Homogenität
EP3838300B1 (fr) * 2019-12-19 2024-03-27 Paul Hartmann AG Procédé de fabrication d'un polymère contenant de l'alginate à des fins médicales, en particulier pour le traitement des plaies
EP4236721A1 (fr) * 2020-10-30 2023-09-06 Rea.deeming Beauty, Inc. DBA Beautyblender Procédés et systèmes de production d'une éponge cosmétique d'origine biologique et mélangeur

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903232A (en) * 1973-10-09 1975-09-02 Grace W R & Co Dental and biomedical foams and method
US4137200A (en) * 1973-10-09 1979-01-30 W. R. Grace & Co. Crosslinked hydrophilic foams and method
US4127515A (en) * 1974-10-21 1978-11-28 Colgate-Palmolive Company Waxing sponge
US4344930A (en) * 1975-10-30 1982-08-17 Colgate-Palmolive Company Skin care sponge
US4548954A (en) * 1983-07-06 1985-10-22 Creative Products Resource Associates, Ltd. Floor cleaning composition
US4806572A (en) * 1987-05-04 1989-02-21 Creative Products Resource Asociates, Ltd. Hydrophilic foam pad for makeup removal
US5065752A (en) * 1988-03-29 1991-11-19 Ferris Mfg. Co. Hydrophilic foam compositions
US5261426A (en) * 1991-05-30 1993-11-16 Creative Products Resource Associates, Ltd. Hydrophilic foam pad for hair styling
US6159487A (en) * 1998-03-24 2000-12-12 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Moistened cosmetic eye treatment fads
US5976616A (en) * 1998-10-02 1999-11-02 H.H. Brown Shoe Technologies, Inc. Polyurethane foam materials with skin conditioning additives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO02085965A1 *

Also Published As

Publication number Publication date
WO2002085965A1 (fr) 2002-10-31
US20040170670A1 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
WO2002085965A1 (fr) Eponges cosmetiques
EP1326577B2 (fr) Nouvelle utilisation d'acides carboxyliques a chaine courte
RU2438649C9 (ru) Косметическое средство с повышенной интенсивностью и устойчивостью запаха
EP1531853B2 (fr) Combinaison synergique de proteines de soie
EP1280496A2 (fr) Produit cosmetique comprenant des derives de 2-furanone
DE10240757A1 (de) Synergistische Kombination von Seidenproteinen
DE202005021949U1 (de) Haarkonditionierende Mittel mit aminofunktionellen Siliconen
EP1179339B1 (fr) Produit cosmétique contenant des extraits de graines de "malvaceae"
EP1232739A1 (fr) Combinaisons de principes actifs comprenant des hydrocarbures et des ingrédients huileux dans une composition cosmétique
DE10259016A1 (de) Kosmetische Schwämme
DE10208678A1 (de) Kosmetische Schwämme
WO2006066642A1 (fr) Shampooing modifiant la couleur des cheveux
DE102009009004A1 (de) Abgabevorrichtung mit einem kosmetischen Fluid
DE102004030885A1 (de) Haarreinigungsmittel mit aminofunktionellen Siliconen
DE10327707A1 (de) Kosmetische Schwämme
EP1813259B1 (fr) Composition déclaircissement et/ou de coloration ayant un potentiel d'irritation réduit
WO2007087860A1 (fr) Agents cosmétiques contenant un polysiloxane et une huile ester ainsi que d'autres principes actifs
EP1675564A1 (fr) Produits contenant de la valeriane
DE102006059569A1 (de) Konditionierende Zusammensetzung von besonders ausgewählten milden anionischen Tensiden und kationischen oder amphoteren Polymeren in Mitteln zur Behandlung keratinischer Fasern
WO2007000223A1 (fr) Produits cosmetiques contenant un compose de polyammonium-polysiloxane et d'autres principes actifs
WO2003035018A1 (fr) Nouvelle utilisation de tensioactifs derives du sucre et de glycerides partiels d'acides gras dans des colorants
EP1776077B1 (fr) Produits de nettoyage capillaire volumateurs
EP1669108B1 (fr) Composition et traitement des cheveux pour réduire l'odeur
EP1786382A1 (fr) Extraits utilises comme agents de structuration
DE102004042099A1 (de) Pflegendes Haarfärbemittel

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030829

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

17Q First examination report despatched

Effective date: 20070914

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080326